Zhang X, Han X, Li C, Cui J, Yuan X, Meng J
J Inflamm Res. 2025; 18:3385-3397.
PMID: 40070925
PMC: 11895693.
DOI: 10.2147/JIR.S482940.
Kingstad-Bakke B, Lee W, Yount Jr B, Cleven T, Park H, Sullivan J
Commun Biol. 2025; 8(1):392.
PMID: 40057586
PMC: 11890755.
DOI: 10.1038/s42003-025-07820-7.
Harti G, Maulida S, Susandi E, Fadjari T, Sumardi U, Alisjahbana B
J Blood Med. 2025; 16:61-74.
PMID: 39926111
PMC: 11806915.
DOI: 10.2147/JBM.S499023.
Guironnet-Paquet A, Hamzeh-Cognasse H, Berard F, Cognasse F, Richard J, Yonis H
Front Immunol. 2025; 15:1492672.
PMID: 39896810
PMC: 11782122.
DOI: 10.3389/fimmu.2024.1492672.
Mruthyunjaya P, Ahmed S, Botabekova A, Baimukhamedov C, Zimba O
Rheumatol Int. 2025; 45(1):29.
PMID: 39812833
DOI: 10.1007/s00296-024-05784-1.
Immune Response Against SARS-CoV-2.
Stufano A, Schino V, Lucchese G
Vaccines (Basel). 2025; 12(12.
PMID: 39772051
PMC: 11680432.
DOI: 10.3390/vaccines12121390.
The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells.
Tu T, Bennani F, Masroori N, Liu C, Nemati A, Rozza N
Commun Biol. 2025; 8(1):14.
PMID: 39762551
PMC: 11704208.
DOI: 10.1038/s42003-024-07350-8.
[Analysis of CMV and EBV infection in healthy populations in China before and after the COVID-19 pandemic].
Zhao Z, Liu Z, Wang Y, Sun Y, Xu L, Zhang X
Zhonghua Xue Ye Xue Za Zhi. 2025; 45(11):986-990.
PMID: 39746690
PMC: 11886679.
DOI: 10.3760/cma.j.cn121090-20240910-00342.
The impact of COVID-19 on accelerating of immunosenescence and brain aging.
Muller L, Di Benedetto S
Front Cell Neurosci. 2024; 18:1471192.
PMID: 39720706
PMC: 11666534.
DOI: 10.3389/fncel.2024.1471192.
COVID-19: A threat to the respiratory system.
Rasool G, Khan W, Khan A, Riaz M, Abbas M, Rehman A
Int J Immunopathol Pharmacol. 2024; 38:3946320241310307.
PMID: 39716038
PMC: 11672396.
DOI: 10.1177/03946320241310307.
The impact of SARS-CoV-2 infection on immunity reconstitution among pediatric patients after allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysis.
Wang X, Liu L, Zhang L, Shang Y, Chen X, Ren Y
Front Pediatr. 2024; 12:1489648.
PMID: 39639950
PMC: 11617172.
DOI: 10.3389/fped.2024.1489648.
Dynamic Changes in Lymphocyte Populations and Their Relationship with Disease Severity and Outcome in COVID-19.
Andrejkovits A, Hutanu A, Manu D, Dobreanu M, Vasiesiu A
Int J Mol Sci. 2024; 25(22).
PMID: 39595989
PMC: 11593669.
DOI: 10.3390/ijms252211921.
Navigating SARS-CoV-2-related immunopathology in Crohn's disease: from molecular mechanisms to therapeutic challenges.
Chen C, Lin Y, Liu K, Huang C, Shih C, Lee Y
Virol J. 2024; 21(1):288.
PMID: 39538233
PMC: 11562311.
DOI: 10.1186/s12985-024-02529-1.
COVID-19 and severe cutaneous allergic reactions to sulfonamides.
Deng E, Craig T, Nguyen D, Al-Shaikhly T
Allergy Asthma Proc. 2024; 45(6):e93-e100.
PMID: 39517080
PMC: 11572944.
DOI: 10.2500/aap.2024.45.240086.
Clinical and Epidemiological Features of Pediatric COVID-19: A Retrospective Study.
Mirkarimi M, Heidari S, Shamsizadeh A, Tahouri K, Alisamir M, Fathi M
Health Sci Rep. 2024; 7(11):e70181.
PMID: 39512246
PMC: 11540839.
DOI: 10.1002/hsr2.70181.
The characteristics of TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients.
Zhou D, Luo Y, Ma Q, Xu Y, Yao X
Virulence. 2024; 15(1):2421987.
PMID: 39468707
PMC: 11540089.
DOI: 10.1080/21505594.2024.2421987.
Immune exhaustion in ME/CFS and long COVID.
Eaton-Fitch N, Rudd P, Er T, Hool L, Herrero L, Marshall-Gradisnik S
JCI Insight. 2024; 9(20).
PMID: 39435656
PMC: 11529985.
DOI: 10.1172/jci.insight.183810.
COVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management.
Zhang S, Wu Y, Mprah R, Wang M
Front Endocrinol (Lausanne). 2024; 15:1434331.
PMID: 39429741
PMC: 11486749.
DOI: 10.3389/fendo.2024.1434331.
Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections.
Paranga T, Pavel-Tanasa M, Constantinescu D, Iftimi E, Plesca C, Miftode I
Front Immunol. 2024; 15:1464480.
PMID: 39376569
PMC: 11456479.
DOI: 10.3389/fimmu.2024.1464480.
Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19.
Li Z, He H, Zhang F, Li H, Jin X, Song Y
Front Immunol. 2024; 15:1448653.
PMID: 39355257
PMC: 11442272.
DOI: 10.3389/fimmu.2024.1448653.
